| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2009 | US20090156460 Cationic betaine precursors to zwitterionic betaines having controlled biological properties |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090156402 4-alkoxy-cyclohexane-1-amino-carboxylic esters and processes for their preparation |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155904 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155822 Process for diagnosing rheumatic diseases |
| 06/18/2009 | US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 |
| 06/18/2009 | US20090155398 Jucara and acai fruit-based dietary supplements |
| 06/18/2009 | US20090155393 Method for prolonging the life of animals |
| 06/18/2009 | US20090155391 Hydroxycitric acid salt composition and method of use for reducing body weight |
| 06/18/2009 | US20090155389 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 06/18/2009 | US20090155387 Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent |
| 06/18/2009 | US20090155384 Methods and compositions for the sustained release of chromium |
| 06/18/2009 | US20090155383 Personal Care Compositions Comprising Undecyl Sulfates |
| 06/18/2009 | US20090155379 Nutritional composition for facilitating muscle pumps |
| 06/18/2009 | US20090155374 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/18/2009 | US20090155372 Method of manufacturing modified release dosage forms |
| 06/18/2009 | US20090155370 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 06/18/2009 | US20090155369 Pharmaceutical composition containing levodopa, entacapone and carbidopa |
| 06/18/2009 | US20090155368 Pharmaceutical compositions |
| 06/18/2009 | US20090155362 Method of cross-linking hyaluronic acid with divinulsulfone |
| 06/18/2009 | US20090155360 Orally disintegrating tablets comprising diphenhydramine |
| 06/18/2009 | US20090155358 Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulation |
| 06/18/2009 | US20090155355 Particles in a capsule |
| 06/18/2009 | US20090155353 Microemulsions for pharmaceutical compositions |
| 06/18/2009 | US20090155352 Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| 06/18/2009 | US20090155349 Methods of treating influenza viral infections |
| 06/18/2009 | US20090155343 Tamsulosin-Containing Transdermal Patch |
| 06/18/2009 | US20090155338 Chronotherapeutic Ocular Delivery System Comprising a Combination of Prostaglandin and a Beta-Blocker for Treating Primary Glaucoma |
| 06/18/2009 | US20090155337 Method and agent for in-situ stabilization of vascular tissue |
| 06/18/2009 | US20090155331 Injectable nanoparticulate olanzapine formulations |
| 06/18/2009 | US20090155326 Layered drug delivery polymer monofilament fibers |
| 06/18/2009 | US20090155319 Method for producing cosmetic and/or dermatological powder |
| 06/18/2009 | US20090155311 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells |
| 06/18/2009 | US20090155307 Immunostimulatory nucleic acid oil-in-water formulations and related methods of use |
| 06/18/2009 | US20090155295 Vaccine |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155276 NOVEL DKKL-1 Splice Product Modulators for Cancer Diagnosis and Therapy |
| 06/18/2009 | US20090155273 Remedies for inflammatory bowel diseases |
| 06/18/2009 | US20090155272 Targeted pharmaceuticals and ligands |
| 06/18/2009 | US20090155268 Growth Factor Binding Constructs Materials and Methods |
| 06/18/2009 | US20090155266 Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases |
| 06/18/2009 | US20090155265 Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies |
| 06/18/2009 | US20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors |
| 06/18/2009 | US20090155244 Methods and compositions for poxvirus a35r protein |
| 06/18/2009 | US20090155241 Prophylactic/therapeutic agent for cancer |
| 06/18/2009 | US20090155240 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 06/18/2009 | US20090155235 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/18/2009 | US20090155234 Detection of mutations in a gene associated with resistance to viral infection, mx1 |
| 06/18/2009 | US20090155230 Novel genes and markers in essential arterial hypertension |
| 06/18/2009 | US20090155224 Dimethyl amino ethyl ether psoralens and methods for their production and use |
| 06/18/2009 | US20090155219 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 06/18/2009 | US20090155212 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 06/18/2009 | US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine |
| 06/18/2009 | US20090155210 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | US20090155209 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/18/2009 | US20090155208 Methods and agents for modulating an immune response |
| 06/18/2009 | US20090155207 Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other Disorders |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090155202 modulating the expression of a gene by forming complexes between dsDNA and novel DNA-binding polymers comprising N-terminal thiophene-containing moieties which exhibit selectivity for T-A base pairs |
| 06/18/2009 | US20090155201 Alkylated poly(allylamine) polymers and methods of use |
| 06/18/2009 | US20090155200 Methods of promoting cartilage healing or cartilage integration |
| 06/18/2009 | US20090155199 Apparatus and methods for pain relief using ultrasound energized polymers |
| 06/18/2009 | US20090155193 Topical Bioadhesive Formulations |
| 06/18/2009 | US20090155187 Drug for inhibiting vascular intimal hyperplasia |
| 06/18/2009 | US20090155186 Compositions and methods for treating inflammatory conditions |
| 06/18/2009 | US20090155185 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 06/18/2009 | US20090155180 Methods and targets for identifying compounds for regulating rhinovirus infection |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155176 Compositions and methods for treatment of diabetic retinopathy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155172 Antibodies to MAGMAS and uses thereof |
| 06/18/2009 | DE202009003549U1 Variabel und präzise dosierbare feste Arzneiform enthaltend ein Antiepileptikum Variable and precisely metered solid dosage form comprising an antiepileptic drug |
| 06/18/2009 | DE102007060918A1 Verfahren zur Herstellung von cycloplatinierten Platin-Komplexen, durch dieses Verfahren hergestellte Platin-Komplexe sowie deren Verwendung A process for the production of cyclo platinized platinum complexes, platinum complexes prepared by this method and their use |
| 06/18/2009 | DE102007059752A1 Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone Functionalized solid polymer nanoparticles comprising epothilones |
| 06/18/2009 | CA2845454A1 Organic compounds useful as inhibitors of phosphodiesterase 1 |
| 06/18/2009 | CA2746551A1 Improved treatment and prophylaxis |
| 06/18/2009 | CA2714401A1 Nutraceutical composition and methods of use |
| 06/18/2009 | CA2714399A1 Nutraceutical composition and methods of use |
| 06/18/2009 | CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709301A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709232A1 Compounds for preventing and treating plasmodium infections |
| 06/18/2009 | CA2709219A1 Solid forms of tenofovir disoproxil |
| 06/18/2009 | CA2709208A1 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption |
| 06/18/2009 | CA2709203A1 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | CA2709109A1 Methods and compositions for prevention or treatment of rsv infection |
| 06/18/2009 | CA2709104A1 Method and composition for treating a serotonin receptor-mediated condition |
| 06/18/2009 | CA2709103A1 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 06/18/2009 | CA2709083A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 06/18/2009 | CA2709021A1 Antibacterial condensed thiazoles |
| 06/18/2009 | CA2708832A1 O-desmethyl-venlafaxine for treating major depressive disorder |
| 06/18/2009 | CA2708793A1 Aminothiazoles and their uses |
| 06/18/2009 | CA2708783A1 Triazolotriazines and triazolopyrazines and the use thereof |
| 06/18/2009 | CA2708780A1 Small molecules for neuronal differentiation of embryonic stem cells |
| 06/18/2009 | CA2708741A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/18/2009 | CA2708706A1 Cannabinoid receptor modulators |